Please assess the completion status of the following clinical trial:

Trial Title: Postoperative Pain Control After Hip Hemiarthroplasty: Intrathecal Morphine vs Periarticular Infiltration of Bupivacaine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* age between 18-90 years~* Co-operative, able to use PCA~* ASA classification 1-3~* no contraindication for Spinal Anesthesia~* patient acceptance for spinal anesthesia~* body weight \> 30 kg.~* BMI between 20-35~* no history of drug allergy, e.g. Local Anesthetics, Paracetamol, etc.~Exclusion Criteria:~* age \> 90 years~* previous Hemiarthroplasty (the same site)~* pathological fracture such as severe infection, bone cancer

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- control (Type: PLACEBO_COMPARATOR): The patient will be performed spinal anesthesia alone, with postoperative PCA
- Morphine (Type: ACTIVE_COMPARATOR): The patient will received intrathecal Morphine for 0.1 mg. in Isobaric bupivacaine in spinal anesthesia and postoperative PCA
- bupivacaine (Type: ACTIVE_COMPARATOR): the patients will be received spinal anesthesia and periarticular tissue infiltration with 0.25% Bupivacaine and postoperative pain control by IV PCA

Based on this trial design, predict the completion outcome and termination type (if applicable).